0001213900-17-011589.txt : 20171108 0001213900-17-011589.hdr.sgml : 20171108 20171108161521 ACCESSION NUMBER: 0001213900-17-011589 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171108 DATE AS OF CHANGE: 20171108 EFFECTIVENESS DATE: 20171108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-298360 FILM NUMBER: 171186788 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0708 D LIVE 0000812796 SOLIGENIX, INC. 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ NEW JERSEY 08540 609-538-8200 DELAWARE Immunotherapeutics Inc. Endorex Corp. Dor BioPharma Inc. DOR BIOPHARMA INC ENDOREX CORP IMMUNOTHERAPEUTICS INC Corporation true Christopher J. Schaber, PhD 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Director Keith L. Brownlie, CPA 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Marco M. Brughera, DVM 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Gregg A. LaPointe, CPA 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Robert J. Rubin, MD 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director Jerome B. Zeldis, PhD 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Director R. Christopher Cavalli, PhD 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Oreola Donini, PhD 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Karen Krumeich 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Adam T. Rumage 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Richard C. Straube, MD MSc 29 Emmons Drive, Suite C-10 Princeton NJ NEW JERSEY 08540 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-11-02 false true false 0 Aegis Capital Corp. 15007 None None 801 7TH AVE., 18TH AND 22ND FLOOR NEW YORK NY NEW YORK 10019 CA CALIFORNIA NY NEW YORK PA PENNSYLVANIA false 1964000 1964000 0 false 6 0 137480 Additionally, the Issuer agreed to (i) sell, for the price of $100, the placement agent a warrant to purchase 19,640 shares of common stock at a price of $2.50 per share and (iii) reimburse certain expenses of the placement agent. 0 false SOLIGENIX, INC. /s/ Christopher J. Schaber Christopher J. Schaber, Ph.D President and Chief Executive Officer 2017-11-07